US FDA approves higher dose of Wegovy
Published on March 19, 2026.
The US Food and Drug Administration has approved a high dose of Wegovy, intended to reduce excess body weight and maintain it long-term. The drug is also being marketed as a powerful anti-inflammatory drug. The company is seeking to prevent future incidents of violence and terrorism.
Read Original Article